Ibrutinib 11014-0417-02
- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- December 20, 2017
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ibrutinib | 70 mg/1 |
Selected Package
11014-0417-02Selected1 BAG in 1 DRUM (11014-0417-2) / 45455 CAPSULE in 1 BAG